Gyre Therapeutics (GYRE) Leases (2019 - 2024)
Historic Leases for Gyre Therapeutics (GYRE) over the last 6 years, with Q4 2024 value amounting to $1.8 million.
- Gyre Therapeutics' Leases rose 27177.91% to $1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.8 million, marking a year-over-year increase of 27177.91%. This contributed to the annual value of $1.8 million for FY2024, which is 27177.91% up from last year.
- Per Gyre Therapeutics' latest filing, its Leases stood at $1.8 million for Q4 2024, which was up 27177.91% from $2.0 million recorded in Q3 2024.
- Over the past 5 years, Gyre Therapeutics' Leases peaked at $3.1 million during Q2 2021, and registered a low of $17000.0 during Q1 2023.
- Over the past 5 years, Gyre Therapeutics' median Leases value was $1.8 million (recorded in 2020), while the average stood at $1.6 million.
- As far as peak fluctuations go, Gyre Therapeutics' Leases crashed by 9924.17% in 2023, and later soared by 225294.12% in 2024.
- Over the past 5 years, Gyre Therapeutics' Leases (Quarter) stood at $1.8 million in 2020, then soared by 49.78% to $2.7 million in 2021, then tumbled by 75.73% to $666000.0 in 2022, then decreased by 26.58% to $489000.0 in 2023, then soared by 271.78% to $1.8 million in 2024.
- Its Leases was $1.8 million in Q4 2024, compared to $2.0 million in Q3 2024 and $2.1 million in Q2 2024.